Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer
Clinical trial NCT00365365 · COMPLETED
Trial details
- NCT number
- NCT00365365
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2011-10-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.